John Gregg

John Gregg

Company: BalinBac Therapeutics, Inc

Job title: CEO


John Gregg leads BalinBac Therapeutics, “The Microbiome Optimization Company”, a biopharmaceutical organization that will transform the treatment of gastro-intestinal conditions in humans and livestock animals. Responsible for corporate vision, strategy, & execution of projects that will revolutionize weight control in people and livestock animals as well as innovatively advancing the treatment of debilitating and deadly GI / infectious diseases.

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.